Extended Data Table 6 Treatment-related adverse events with NCI-CTCAE any Grade and Grade 3 or above by preferred term

From: First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

  1. (1) Treatment-related adverse event is defined as any treatment-emergent adverse event that is related to any treatment determined by the investigators.
  2. MedDRA version 25.1, NCI-CTCAE version 5.0. MedDRA: Medical Dictionary for Regulatory Activities. SAS: safety analysis set.